PRAZOSIN Drug Patent Profile

When do Prazosin patents expire, and when can generic versions of Prazosin launch?

Prazosin is a drug marketed by Alembic, Am Therap, Ani Pharms, Appco, Aurobindo Pharma Ltd, Dava Pharms Inc, Granules, Lannett Co Inc, Mankind Pharma, MSN, Mylan, Novitium Pharma, Purepac Pharm, Teva Pharms, and Watson Labs. and is included in twenty-three NDAs.

The generic ingredient in PRAZOSIN is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Prazosin

A generic version of PRAZOSIN was approved as prazosin hydrochloride by TEVA PHARMS on September 12^th, 1988.

Summary for PRAZOSIN

US Patents:	0
Applicants:	15
NDAs:	23
Drug Prices:	Drug price information for PRAZOSIN
Drug Sales Revenues:	Drug sales revenues for PRAZOSIN
What excipients (inactive ingredients) are in PRAZOSIN?	PRAZOSIN excipients list
DailyMed Link:	PRAZOSIN at DailyMed

See drug prices for PRAZOSIN

See drug sales revenues for PRAZOSIN

US Patents and Regulatory Information for PRAZOSIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	071745-003	Sep 12, 1988	AB	RX	No	No
Mylan	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072575-002	May 16, 1989	AB	RX	No	No
Watson Labs	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072609-001	May 16, 1989		DISCN	No	No
Msn	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	216727-001	Sep 17, 2024	AB	RX	No	No
Mylan	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072575-001	May 16, 1989	AB	RX	No	No
Msn	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	216727-002	Sep 17, 2024	AB	RX	No	No